Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Hippe

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
British Journal of Haematology|March 23, 1999
Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of LifeM L Stead, J M Brown, G Velikova, et al.
European Journal of Haematology|August 1, 1993
Multiple myeloma treated with mitoxantrone in combination with vincristine and prednisolone (NOP regimen) versus melphalan and prednisolone: a phase III study. Nordic Myeloma Study Group (NMSG)N Keldsen, O W Bjerrum, I M Dahl, et al.
British Journal of Haematology|January 1, 1991
Refractory myelomatosis treated with mitoxantrone in combination with vincristine and prednisone (NOP-regimen): a phase II study. The Nordic Myeloma Study Group (NMSG)P Gimsing, O W Bjerrum, E Brandt, et al.
Haemostasis|January 1, 1996
Clinical experience with recombinant factor VIIa in patients with thrombocytopeniaJ Kristensen, A Killander, E Hippe, et al.
Autoimmunity|January 1, 1991
Anti-thyroid peroxidase antibodies in thyroid disorders and non-thyroid autoimmune diseasesU Feldt-Rasmussen, M Høier-Madsen, K Bech, et al.
Leukemia|June 1, 1991
Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, DenmarkO P Hansen, J Pedersen-Bjergaard, J Ellegaard, et al.
Leukemia|January 1, 1997
Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial. Danish Society of Haematology Study Group on AMLP de Nully Brown, T Hoffmann, O P Hansen, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2007
An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myelomaK Cocks, D Cohen, F Wisløff, et al.
Medical Oncology (Northwood, London, England)|January 10, 2002
Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell supportN Gulbrandsen, F Wisløff, L Brinch, et al.
Blood|December 23, 1999
Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study GroupS Lenhoff, M Hjorth, E Holmberg, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
British Journal of Haematology|March 23, 1999
Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of LifeM L Stead, J M Brown, G Velikova, et al.
European Journal of Haematology|August 1, 1993
Multiple myeloma treated with mitoxantrone in combination with vincristine and prednisolone (NOP regimen) versus melphalan and prednisolone: a phase III study. Nordic Myeloma Study Group (NMSG)N Keldsen, O W Bjerrum, I M Dahl, et al.
British Journal of Haematology|January 1, 1991
Refractory myelomatosis treated with mitoxantrone in combination with vincristine and prednisone (NOP-regimen): a phase II study. The Nordic Myeloma Study Group (NMSG)P Gimsing, O W Bjerrum, E Brandt, et al.
Haemostasis|January 1, 1996
Clinical experience with recombinant factor VIIa in patients with thrombocytopeniaJ Kristensen, A Killander, E Hippe, et al.
Autoimmunity|January 1, 1991
Anti-thyroid peroxidase antibodies in thyroid disorders and non-thyroid autoimmune diseasesU Feldt-Rasmussen, M Høier-Madsen, K Bech, et al.
Leukemia|June 1, 1991
Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, DenmarkO P Hansen, J Pedersen-Bjergaard, J Ellegaard, et al.
Leukemia|January 1, 1997
Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial. Danish Society of Haematology Study Group on AMLP de Nully Brown, T Hoffmann, O P Hansen, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2007
An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myelomaK Cocks, D Cohen, F Wisløff, et al.
Medical Oncology (Northwood, London, England)|January 10, 2002
Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell supportN Gulbrandsen, F Wisløff, L Brinch, et al.
Blood|December 23, 1999
Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study GroupS Lenhoff, M Hjorth, E Holmberg, et al.
Pageof 12